Canertinib dihydrochloride
Canertinib dihydrochloride Basic information
- Product Name:
- Canertinib dihydrochloride
- Synonyms:
-
- CANERTINIB DIHYDROCHLORIDE
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride
- Canertinib Dihydrochloride (CI-1033 HCl)
- Canertinib (CI-1033) HCl
- CANERTINIB;CI-1033 DIHYDROCHLORIDE;PD-183805 DIHYDROCHLORIDE;CI1033 DIHYDROCHLORIDE;CI 1033 DIHYDROCHLORIDE;PD183805 DIHYDROCHLORIDE;PD 183805 DIHYDROCHLORIDE
- Canertinib dihydrochloride (CI-1033
- Canertinib.2HCL
- CI-1033
- CAS:
- 289499-45-2
- MF:
- C24H27Cl3FN5O3
- MW:
- 558.86
- Product Categories:
-
- Inhibitors
- API
- Mol File:
- 289499-45-2.mol
Canertinib dihydrochloride Chemical Properties
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- solubility
- DMSO: >10mg/mL
- form
- solid
- color
- Light yellow to green yellow
Canertinib dihydrochloride Usage And Synthesis
Uses
CI-1033 is a potent inhibitor of EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, respectively.
Uses
Canertinib Dihydrochloride is a water-soluble, EGFR, HER2, and ErbB-4 tyrosine kinase inhibitor.
Uses
The HER family of receptor tyrosine kinases, EGFR, HER2, HER3, and HER4, mediate proliferation, migration, adhesion, differentiation, and survival in many different cell types and have been implicated in the development and progression of a variety of human tumors.Canertinib dihydrochloride is an irreversible quinazoline-based HER family tyrosine kinase inhibitor with IC50 values of 0.8, 19, and 7 nM for blocking in vitro activity of EGFR, HER2, and HER4, respectively. As a broadly applicable anti-cancer agent, it has been used to suppress proliferation of malignant peripheral nerve sheath tumor cells (effective concentration of 250-500 nM), to inhibit growth and induce dose-dependent apoptosis in a panel of neuroblastoma cell lines (IC50s = 0.94-2.45 μM), and to reduce proliferation of acute myeloid leukemia cells (IC50 = 0.27 μM). Canertinib dihydrochloride also displays anti-neoplastic activity towards T98G glioblastoma cells, HCT8 colorectal carcinoma cells, and cells expressing the breast cancer resistance protein.
storage
Store at -20°C
Canertinib dihydrochlorideSupplier
- Tel
- sales@boylechem.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
- Tel
- 021-58099652-8005 13585536065
- bin.wu@shlschem.com
- Tel
- 86-0571-85151182
Canertinib dihydrochloride(289499-45-2)Related Product Information
- Moroxydine hydrochloride
- D-Glucosamine hydrochloride
- Pyridine hydrochloride
- 4-Methoxyphenylacetone
- Dimethomorph
- Triethylamine hydrochloride
- 2-Aminoethylammonium chloride
- DIPHENYLAMINE HYDROCHLORIDE
- ALTRENOGEST
- Glycine
- Moroxydine
- CANERTINIB
- Betaine
- L-Lysine hydrochloride
- Methoxyammonium chloride
- Epichlorohydrin
- Sulfanilamide
- 3-Aminobenzenesulfonamide